Presentations

Selected presentations by Senopsys staff include:

• "An Investigation of the Relationship Between Eszopiclone Tablet Coating and Initial Dysgeusia Using the Flavor Profile Method" (Sepracor), 2009 AAPS Annual Meeting.
• “Development of a Palatable, Oral Solution of Tolevamer™” (Genzyme),
  2006 AAPS Annual Meeting.
• “The Development of Palatable Pediatric Formulations - Establishing the Target, Measuring Progress and Verifying Acceptability,” Pre-Clinical and Clinical Strategies for Pediatric Drug Development, February 2006.
• “Developing Palatable Pharmaceuticals,” SRI Drug Delivery Technologies and Deal Making Summit, September 2005.
• "A Sensory Panel Method for Measuring the Mouthfeel Characteristics and Ease-of-swallowing of Film Coated Tablets” (Colorcon), 2004 AAPS Annual Meeting.
• "Development of a Palatable Oral Suspension Containing Tenofovir Disoproxil Fumarate” (Gilead Sciences), 2003 AAPS Annual Meeting.
• "Development of a Palatable Oral Suspension Dosage form of Cefditoren Pivoxil" (TAP Pharmaceuticals), 2002 AAPS Annual Meeting.
• "Development of a Palatable Stable Pediatric Oral Suspension Containing Emivirine" (Triangle Laboratories), 2000 AAPS Annual Meeting.
• "Development of KALETRA™ Oral Solution, a Palatable Oral Solution Containing Lopinavir (ABT-378) and Ritonavir" (Abbott Laboratories), 2000 AAPS Annual Meeting.
• "Development of a Palatable, Oral Liquid Drug Product for Sodium n-(8-[2-hydroxybenzoyl]-amino) caprylate (SNAC) and Heparin Sodium" (Emisphere Technologies), 1999 AAPS Annual Meeting.
• Benchmarking Studies:
• “Flavor Benchmarking of Leading OTC Pediatric Analgesics," 2003 AAPS Annual Meeting.
• "Flavor Benchmarking of Leading OTC Cough, Cold and Flu Remedies," 2001 AAPS Annual Meeting.